Pediatric transverse myelitis

Neurology

Volumn 87, Issue 9, 2016, Pages S46-S52

  Absoud, Michael ^a   Greenberg, Benjamin M ^b   Lim, Ming ^a   Lotze, Tim ^c,d   Thomas, Terrence ^e   Deiva, Kumaran ^f  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d TEXAS CHILDREN S HOSPITAL   (United States)

^e KK WOMEN'S AND CHILDREN'S HOSPITAL   (Singapore)

^f BICÊTRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRAIN ABSCESS; CHILD; CHILDHOOD DISEASE; CLINICAL FEATURE; CLINICAL OUTCOME; DIFFERENTIAL DIAGNOSIS; GUILLAIN BARRE SYNDROME; HUMAN; MULTICENTER STUDY (TOPIC); MYELITIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SPINAL CORD TUMOR; MYELITIS, TRANSVERSE; PATHOPHYSIOLOGY; PEDIATRICS; TREATMENT OUTCOME;

CHILD; DIAGNOSIS, DIFFERENTIAL; HUMANS; MYELITIS, TRANSVERSE; NEUROIMAGING; PEDIATRICS; TREATMENT OUTCOME;

EID: 85003434307     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000002820     Document Type: Article

References (44)

1. Transverse Myelitis Consortium Working Group. Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology 2002;59:499-505.
2. Krupp LB, Tardieu M, Amato MP, et al. International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions. Mult Scler 2013;19:1261-1267.
3. Deiva K, Absoud M, Hemingway C, et al. Acute idiopathic transverse myelitis in children: early predictors of relapse and disability. Neurology 2015;84:341-349.
4. Wolf VL, Lupo PJ, Lotze TE. Pediatric acute transverse myelitis overview and differential diagnosis. J Child Neurol 2012;27:1426-1436.
5. De Goede CG, Holmes EM, Pike MG. Acquired transverse myelopathy in children in the United Kingdom-A 2 year prospective study. Eur J Paediat Neurol 2010;14: 479-487.
6. Banwell B, Kennedy J, Sadovnick D, et al. Incidence of acquired demyelination of the CNS in Canadian children. Neurology 2009;72:232-239.
7. Absoud M, Lim MJ, Chong WK, et al. Paediatric acquired demyelinating syndromes: incidence, clinical and magnetic resonance imaging features. Mult Scler 2013;19:76-86.
8. Pidcock FS, Krishnan C, Crawford TO, Salorio CF, Trovato M, Kerr DA. Acute transverse myelitis in childhood: center-based analysis of 47 cases. Neurology 2007; 68:1474-1480.
9. Alper G, Petropoulou KA, Fitz CR, Kim Y. Idiopathic acute transverse myelitis in children: an analysis and discussion of MRI findings. Mult Scler 2011;17:74-80.
10. DaJusta DG, Wosnitzer MS, Barone JG. Persistent motor deficits predict long-term bladder dysfunction in children following acute transverse myelitis. J Urol 2008;180: 1774-1777.
11. Miyazawa R, Ikeuchi Y, Tomomasa T, Ushiku H, Ogawa T, Morikawa A. Determinants of prognosis of acute transverse myelitis in children. Pediatr Int 2003; 45:512-516.
12. Thomas T, Branson HM, Verhey LH, et al. The demographic, clinical, and magnetic resonance imaging (MRI) features of transverse myelitis in children. J Child Neurol 2012;27:11-21.
13. Meyer P, Leboucq N, Molinari N, et al. Partial acute transverse myelitis is a predictor of multiple sclerosis in children. Mult Scler 2014;20:1485-1493.
14. DeSena A, Graves D, Morriss MC, Greenberg BM. Transverse myelitis plus syndrome and acute disseminated encephalomyelitis plus syndrome: A case series of 5 children. JAMA Neurol 2014;71:624-629.
15. Maynard FM Jr, Bracken MB, Creasey G, et al. International standards for neurological and functional classification of spinal cord injury. Spinal Cord 1997;35:266-274.
16. Scott TF, Frohman EM, De Seze J, et al. Evidence-based guideline: clinical evaluation and treatment of transverse myelitis: report of the therapeutics and Technology assessment Subcommittee of the American Academy of neurology. Neurology 2011;77:2128-2134.
17. Marchioni E, Ravaglia S, Montomoli C, et al. Postinfectious neurologic syndromes: A prospective cohort study. Neurology 2013;80:882-889.
18. Messacar K, Schreiner TL, Maloney JA, et al. A cluster of acute flaccid paralysis and cranial nerve dysfunction temporally associated with an outbreak of enterovirus D68 in children in Colorado, USA. Lancet 2015;385: 1662-1671.
19. Rengarajan B, Venkateswaran S, McMillan HJ. Acute asymmetrical spinal infarct secondary to fibrocartilaginous embolism. Childs Nerv Syst 2015;31:487-491.
20. Absoud M, Lim MJ, Appleton R, et al. Paediatric neuromyelitis optica: clinical, MRI of the brain and prognostic features. J Neurol Neurosurg Psychiatry 2015;86: 470-472.
21. Dhaunchak AS, Becker C, Schulman H, et al. Implication of perturbed axoglial apparatus in early pediatric multiple sclerosis. Ann Neurol 2012;71:601-613.
22. Flanagan EP, Weinshenker BG, Krecke KN, et al. Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders. JAMA Neurol 2015;72:81-87.
23. Sethi V, Yousry TA, Muhlert N, et al. Improved detection of cortical MS lesions with phase-sensitive inversion recovery MRI. J Neurol Neurosurg Psychiatry 2012;83: 877-882.
24. Kearney H, Miller DH, Ciccarelli O. Spinal cord MRI in multiple sclerosis-diagnostic, prognostic and clinical value. Nat Rev Neurol 2015;11:327-338.
25. Kerr DA, Ayetey H. Immunopathogenesis of acute transverse myelitis. Curr Opin Neurol 2002;15:339-347.
26. Nakano I, Mannen T, Mizutani T, Yokohari R. Peripheral white matter lesions of the spinal cord with changes in small arachnoid arteries in systemic lupus erythematosus. Clin Neuropathol 1989;8:102-108.
27. Krishnan C, Kaplin AI, Deshpande DM, Pardo CA, Kerr DA. Transverse Myelitis: pathogenesis, diagnosis and treatment. Front Biosci 2004;9:1483-1499.
28. Awad A, Stuve O. Idiopathic transverse myelitis and neuromyelitis optica: clinical profiles, pathophysiology and therapeutic choices. Curr Neuropharmacol 2011;9: 417-428.
29. Beh SC, Greenberg BM, Frohman T, Frohman EM. Transverse myelitis. Neurol Clin 2013;31:79-138.
30. Tobin WO, Weinshenker BG, Lucchinetti CF. Longitudinally extensive transverse myelitis. Curr Opin Neurol 2014;27:279-289.
31. Krishnan C, Kerr DA. Idiopathic transverse myelitis. Arch Neurol 2005;62:1011-1013.
32. Horellou P, Wang M, Keo V, et al. Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis. J Neuroimmunology 2015;289:1-7.
33. Kaplin AI, Deshpande DM, Scott E, et al. IL-6 induces regionally selective spinal cord injury in patients with the neuroinflammatory disorder transverse myelitis. J Clin Invest 2005;115:2731-2741.
34. Trebst C, Jarius S, Berthele A, et al. Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS). J Neurol 2014;261:1-16.
35. Hacohen Y, Absoud M, Woodhall M, et al. Autoantibody biomarkers in childhood-acquired demyelinating syndromes: results from a national surveillance cohort. J Neurol Neurosurg Psychiatry 2014;85:456-461.
36. Hacohen Y, Absoud M, Deiva K, et al. Myelin oligodendrocyte glycoprotein antibodies are associated with a non-MS course in children. Neurol Neuroimmunol Neuroinflamm 2015;2:e81. doi: 10.1212/NXI.0000000000000081.
37. Defresne P, Hollenberg H, Husson B, et al. Acute transverse myelitis in children: clinical course and prognostic factors. J Child Neurol 2003;18:401-406.
38. Defresne P, Meyer L, Tardieu M, et al. Efficacy of high dose steroid therapy in children with severe acute transverse myelitis. J Neurol Neurosurg Psychiatry 2001;71: 272-274.
39. Kitley J, Waters P, Woodhall M, et al. Neuromyelitis optica spectrum disorders with aquaporin-4 and myelinoligodendrocyte glycoprotein antibodies: A comparative study. JAMA Neurol 2014;71:276-283.
40. Graves DE, Frankiewicz RG, Donovan WH. Construct validity and dimensional structure of the ASIA motor scale. J Spinal Cord Med 2006;29:39-45.
41. Greenberg BM, Thomas KP, Krishnan C, Kaplin AI, Calabresi PA, Kerr DA. Idiopathic transverse myelitis: corticosteroids, plasma exchange, or cyclophosphamide. Neurology 2007;68:1614-1617.
42. Bigi S, Banwell B, Yeh EA. Outcomes after early Administration of plasma exchange in pediatric central nervous system inflammatory demyelination. J Child Neurol 2015; 30:874-880.
43. Llufriu S, Castillo J, Blanco Y, et al. Plasma exchange for acute attacks of CNS demyelination: predictors of improvement at 6 months. Neurology 2009;73:949-953.
44. Absoud M, Gadian J, Hellier J, et al. Protocol for a multicentre randomiSed controlled TRial of IntraVEnous immunoglobulin versus standard therapy for the treatment of transverse myelitis in adults and children (STRIVE). BMJ Open 2015;25:e008312. doi: 10.1136/bmjopen-2015-008312.